Dow Up 0.51% Nasdaq Up 0.24%

Lpath Inc. (LPTN)

-NasdaqCM
2.57 Down 0.03(1.15%) Nov 21, 4:00PM EST
Prev Close:2.60
Open:2.60
Bid:2.50 x 200
Ask:N/A
1y Target Est:14.00
Beta:-0.44
Next Earnings Date:N/A
Day's Range:2.55 - 2.63
52wk Range:2.55 - 5.30
Volume:41,127
Avg Vol (3m):29,208
Market Cap:49.54M
P/E (ttm):N/A
EPS (ttm):-0.77
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):64.25
P/S (ttm):7.75
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.13
Quarterly EPS Est (Dec-14) :-0.34
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Lpath, Inc., a biotechnology company, focuses on the discovery and development of lipidomic-based therapeutic antibodies for treating a range of human diseases primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback